Siemens Health Rg
SHL
EUR
STOCK MARKET:
ETR
Closed
 
...
Price in deferred time of 15 minutes
Last quote
03/28/2024 - 17:35:31
Bid
03/28/2024 - 17:30:00
Bid
Volume
Ask
03/28/2024 - 17:30:00
Ask
Volume
56.72
+0.34 ( +0.60% )
56.64
860
56.70
3,483
More information
Analysis by TheScreener
26.03.2024
Evaluation Neutral  
Interest Strong  
Sensibility Middle  
Analysis date: 26.03.2024
Global Evaluation
  Neutral
The stock is classified in the neutral zone since 22.03.2024.
Interest
  Strong
Strong interest since 19.03.2024.
Earnings Rev Trend
  0.10
 
Compared to seven weeks ago, the analysts have not significantly revised their earnings per share estimates (changes between +1% and -1% are considered neutral). But the last significant trend is positive since 19.01.2024 at a price of 51.98.
Evaluation
  Undervalued
 
Based on its growth potential and our own criteria, at its current price the stock is moderately undervalued.
MT Tech Trend
  Neutral
 
The stock is currently trading close to its forty day moving average (changes between +1.75% and -1.75% are considered neutral). Prior to this (since 03.11.2023), the stock traded above its moving average. The confirmed Technical Reverse point (Tech Reverse - 1.75%) is 54.061.
4wk Rel Perf
  -3.59%
 
The four week relative underperformance versus STOXX600 is 3.59%.
Sensibility
  Middle
Moderate, no change over 1 year.
Bear Market Factor
  Middle
On average, the stock is likely to decline with the index.
Bad News Factor
  Low
When the stock's pressure is specific, the market sanction on average is 1.56%.
Mkt Cap in $bn
  66.93
With a market capitalization >$8bn, SIEMENS HEALTHINEERS is considered a large-cap stock.
G/PE Ratio
  1.02
A ratio (Forecasted Growth + Estimated Dividend Yield/ Estimated Price Earnings) higher than 0.9 indicates that the stock's price presents a discount to growth of .
LT P/E
  18.35
The estimated PE is for the year 2026.
LT Growth
  16.58%
The annualized growth estimate is for the current year to 2026.
Avg. Nb analysts
  20
Over the last seven weeks, an average of 20 analysts provided earnings per share estimates.
Dividend Yield
  2.05%
The twelve month estimated dividend yield represents 37.57% of earnings forecasts.
Beta
  107
For 1% of index variation, the stock varies on average by 1.07%.
Correlation
  0.58
57.95% of stock movements are explained by index variations.
Value at Risk
  6.64
The value at risk is estimated at EUR 6.64. The risk is therefore 12.01%. This value is based on the historical volatility for a medium time period (1 month) with a confidence of 95%.
First Analysis Date
  22.06.2018